---
title: "Sangamo amends 8-K to file asset purchase agreement exhibits"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290607256.md"
description: "Sangamo Therapeutics filed an amended Form 8-K to include two previously omitted exhibits related to asset purchase agreements with Eli Lilly and Astellas Gene Therapies, dated June 22, 2026. This amendment supplements the company's original report filed on June 23, 2026, with no other changes to the initial disclosures."
datetime: "2026-06-23T20:42:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290607256.md)
  - [en](https://longbridge.com/en/news/290607256.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290607256.md)
---

# Sangamo amends 8-K to file asset purchase agreement exhibits

-   Sangamo Therapeutics filed an amended Form 8-K to add two previously omitted exhibits to its June 23, 2026 report. \* The amendment filed the June 22, 2026 asset purchase agreements involving Eli Lilly and Astellas Gene Therapies. \* No other disclosures in the original 8-K were changed. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sangamo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-279630), on June 23, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [SGMO.US](https://longbridge.com/en/quote/SGMO.US.md)
- [4503.JP](https://longbridge.com/en/quote/4503.JP.md)
- [ALPMY.US](https://longbridge.com/en/quote/ALPMY.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [LLYX.US](https://longbridge.com/en/quote/LLYX.US.md)
- [ELIS.US](https://longbridge.com/en/quote/ELIS.US.md)
- [LLYZ.US](https://longbridge.com/en/quote/LLYZ.US.md)
- [ELIL.US](https://longbridge.com/en/quote/ELIL.US.md)
- [SGMOQ.US](https://longbridge.com/en/quote/SGMOQ.US.md)

## Related News & Research

- [LLY: Q2 2026 revenue surged 48% to $23B, driving raised full-year guidance and robust pipeline progress](https://longbridge.com/en/news/294955478.md)
- [Behzad Aghazadeh Holds Board Seat at Scribe Therapeutics with 16.37% Stake](https://longbridge.com/en/news/294437888.md)
- [Is Eli Lilly Stock Running out of Steam?](https://longbridge.com/en/news/294722801.md)
- [Lilly Opens Pre-Approval Access to Its Next Obesity Drug](https://longbridge.com/en/news/294856312.md)
- [Eli Lilly (LLY) Wins FDA Breakthrough Status For Olomorasib In Pancreatic Cancer](https://longbridge.com/en/news/294846325.md)